Clare Kahn
Insider Reports History
- Location
- Cambridge, MA
- Signature
- /s/ Jonathan Allan, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Clare Kahn:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Solid Biosciences Inc. | Director | Common Stock | 2,960 | $15,794 | $5.34 | 11 Mar 2025 | Direct |
| Solid Biosciences Inc. | Director | Director Stock Option (Right to Buy) | 77,500 | 12 Jun 2025 | Direct | ||
| Stoke Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 30,782 | 03 Apr 2026 | Direct |
Insider Reports Filed by Clare Kahn
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | 03 Apr 2026 | 1 | $0 | 4 | Director | 07 Apr 2026, 19:09 |
| STOK | Stoke Therapeutics, Inc. | 03 Apr 2026 | 0 | $0 | 3 | Director | 07 Apr 2026, 19:08 |
| SLDB | Solid Biosciences Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:25 |
| SLDB | Solid Biosciences Inc. | 11 Mar 2025 | 1 | +$9,924 | 4 | Director | 13 Mar 2025, 16:05 |
| SLDB | Solid Biosciences Inc. | 11 Jun 2024 | 1 | $0 | 4 | Director | 13 Jun 2024, 16:06 |
| SLDB | Solid Biosciences Inc. | 07 Jun 2024 | 1 | +$8,442 | 4 | Director | 11 Jun 2024, 14:15 |
| SLDB | Solid Biosciences Inc. | 06 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 21:22 |
| SLDB | Solid Biosciences Inc. | 13 Dec 2022 | 1 | $0 | 4 | Director | 15 Dec 2022, 17:10 |
| SLDB | Solid Biosciences Inc. | 07 Jun 2022 | 2 | $0 | 4 | Director | 09 Jun 2022, 17:10 |